Published in Radiother Oncol on April 01, 1994
NCCN Task Force Report: Bone Health in Cancer Care. J Natl Compr Canc Netw (2009) 1.97
Differences in treatment patterns among patients with castration-resistant prostate cancer treated by oncologists versus urologists in a US managed care population. Cancer Manag Res (2011) 1.81
The management of painful bone metastases with an emphasis on radionuclide therapy. J Natl Med Assoc (2007) 1.55
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer. Clin Cancer Res (2013) 1.51
Castration-resistant prostate cancer: mechanisms, targets, and treatment. Prostate Cancer (2012) 1.47
Adverse events in nuclear medicine - cause for concern? Eur J Nucl Med Mol Imaging (2012) 1.41
Percutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trial. Cancer (2010) 1.40
EANM procedure guideline for treatment of refractory metastatic bone pain. Eur J Nucl Med Mol Imaging (2008) 1.18
Prostate cancer: 10. Palliative care. CMAJ (1999) 1.16
Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease. Cancer Manag Res (2013) 1.00
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone. Br J Cancer (2002) 0.98
Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases. Cancer Lett (2012) 0.95
Prostate cancer: 11. Alternative approaches and the future of treatment. CMAJ (1999) 0.93
Targeting bone metastases in prostate cancer: improving clinical outcome. Nat Rev Urol (2015) 0.92
Bone-targeted therapies in metastatic castration-resistant prostate cancer: evolving paradigms. Prostate Cancer (2013) 0.91
Less pain does equal better quality of life following strontium-89 therapy for metastatic prostate cancer. Br J Cancer (2001) 0.89
A novel study investigating the therapeutic outcome of patients with lytic, mixed and sclerotic bone metastases treated with combined radiotherapy and ibandronate. Clin Exp Metastasis (2007) 0.87
A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone. Eur J Nucl Med Mol Imaging (2006) 0.86
Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new data. Oncologist (2014) 0.83
Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer. Clin Adv Hematol Oncol (2010) 0.82
Pathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments. Inflammopharmacology (2013) 0.82
The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer. Ther Adv Urol (2015) 0.81
Bone-targeted agents: preventing skeletal complications in prostate cancer. Urol Clin North Am (2012) 0.80
Strontium 89 in the treatment of pain due to diffuse osseous metastases: a university hospital experience. J Natl Med Assoc (2002) 0.78
Analgesia for patients with advanced disease: 2. Postgrad Med J (2004) 0.78
Comparative efficacy, tolerability, and survival outcomes of various radiopharmaceuticals in castration-resistant prostate cancer with bone metastasis: a meta-analysis of randomized controlled trials. Drug Des Devel Ther (2015) 0.78
Widespread osteoblastic metastases and marked elevation of CA19-9 as a presentation of signet ring cell gastric carcinoma. J Gastrointest Oncol (2016) 0.75
Novel approaches in the pharmacotherapy of skeletal-related events in metastatic castrate-resistant prostate cancer. Anticancer Res (2012) 0.75
Update in palliative management of hormone refractory cancer of prostate. Indian J Urol (2007) 0.75
Optimizing bone health and minimizing skeletal morbidity in men with prostate cancer. Hematol Oncol Clin North Am (2013) 0.75
Radium-223 for the treatment of castration-resistant prostate cancer. Onco Targets Ther (2015) 0.75
Radiotherapeutic approaches to metastatic disease. World J Urol (2003) 0.75
Radium-223 dichloride: illustrating the benefits of a multidisciplinary approach for patients with metastatic castration-resistant prostate cancer. J Multidiscip Healthc (2015) 0.75
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med (2000) 10.25
Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry (2000) 5.21
Climate-driven ecosystem succession in the Sahara: the past 6000 years. Science (2008) 4.53
Assessment and treatment of suicidal patients. N Engl J Med (1997) 3.85
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet (2005) 3.75
Role of choloride transport in regulation of intracellular pH. Nature (1976) 3.31
Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol (2003) 3.10
Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet (2001) 3.06
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab (2001) 2.61
Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital. BJU Int (2003) 2.29
Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy--a systematic review of randomised trials. Clin Oncol (R Coll Radiol) (2003) 2.28
Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol (1999) 2.25
Perfusion of the spleen with blood containing prostaglandin E1: transmitter liberation and uptake. Proc R Soc Lond B Biol Sci (1969) 2.11
Stoichiometry and ion dependencies of the intracellular-pH-regulating mechanism in squid giant axons. J Gen Physiol (1983) 2.10
Detection of micrometastases in patients with primary breast cancer. Lancet (1983) 2.07
Sodium-calcium exchange and calcium-calcium exchange in internally dialyzed squid giant axons. J Membr Biol (1975) 2.07
Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. J Immunol Methods (2001) 2.01
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Cochrane Database Syst Rev (2006) 1.97
A non-circadian role for cAMP signaling and CREB activity in Drosophila rest homeostasis. Nat Neurosci (2001) 1.95
Sequences flanking the centromere of human chromosome 10 are a complex patchwork of arm-specific sequences, stable duplications and unstable sequences with homologies to telomeric and other centromeric locations. Hum Mol Genet (1999) 1.94
Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol) (1996) 1.93
Systemic treatments for metastatic cutaneous melanoma. Cochrane Database Syst Rev (2000) 1.88
Selective mating, assortative mating, and inbreeding: definitions and implications. Eugen Q (1968) 1.85
Calcium efflux from internally dialyzed squid axons: the influence of external and internal cations. J Supramol Struct (1974) 1.83
A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer. Clin Oncol (R Coll Radiol) (2007) 1.75
Chronic testicular pain following vasectomy. Br J Urol (1992) 1.71
Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med (2001) 1.69
Cell-activation responses to cytomegalovirus infection relationship to the phasing of CMV replication and to the induction of cellular damage. Subcell Biochem (1989) 1.68
Calcium efflux from barnacle muscle fibers. Dependence on external cations. J Gen Physiol (1974) 1.67
Intensity modulated radiation therapy: a clinical review. Br J Radiol (2000) 1.62
Prognostic factors in hormone-resistant progressing cancer of the prostate. Ann Oncol (1992) 1.61
The noradrenaline content of the vas deferens of the guinea-pig. Proc R Soc Lond B Biol Sci (1970) 1.58
Nitrogen metabolite signalling involves the C-terminus and the GATA domain of the Aspergillus transcription factor AREA and the 3' untranslated region of its mRNA. EMBO J (1996) 1.58
A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma. Cancer Treat Rev (2008) 1.57
ATP-Dependent chloride influx into internally dialyzed squid giant axons. J Membr Biol (1976) 1.57
Chronic testicular pain: an overview. Eur Urol (2004) 1.57
Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest (1996) 1.56
Influence of cyclic AMP on intracellular pH regulation and chloride fluxes in barnacle muscle fibers. Nature (1978) 1.56
Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol (2000) 1.54
EORTC-GCG process quality indicators for ovarian cancer surgery. Eur J Cancer (2008) 1.53
Endoscopy-based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: a randomized controlled trial. Gastrointest Endosc (1999) 1.53
Intravesical bacillus Calmette-Guérin is superior to mitomycin C in reducing tumour recurrence in high-risk superficial bladder cancer: a meta-analysis of randomized trials. BJU Int (2004) 1.50
A systematic review of intravesical bacillus Calmette-Guérin plus transurethral resection vs transurethral resection alone in Ta and T1 bladder cancer. BJU Int (2001) 1.50
Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol (2003) 1.49
A randomized study of the use of a customized immobilization system in the treatment of prostate cancer with conformal radiotherapy. Radiother Oncol (2000) 1.49
The changing role of surgery in metastatic non-seminomatous germ cell tumour. Br J Cancer (1992) 1.49
Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone. Radiother Oncol (2001) 1.49
Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother Oncol (1997) 1.47
Active transport of chloride by the giant neuron of the Aplysia abdominal ganglion. J Gen Physiol (1972) 1.47
How should new treatments for benign prostatic hyperplasia be assessed? BMJ (1993) 1.46
Use of antisera to epithelial membrane antigen for the cytodiagnosis of malignancy in serous effusions. J Clin Pathol (1981) 1.46
Recovery of serum testosterone, LH and FSH levels following neoadjuvant hormone cytoreduction and radical radiotherapy in localized prostate cancer. Clin Oncol (R Coll Radiol) (2001) 1.46
Comparison of treatment techniques for conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities. Radiother Oncol (1995) 1.43
Cloning, characterization, and chromosomal mapping of a human electroneutral Na(+)-driven Cl-HCO3 exchanger. J Biol Chem (2000) 1.43
RAPPER: the radiogenomics of radiation toxicity. Clin Oncol (R Coll Radiol) (2013) 1.42
STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial. Clin Oncol (R Coll Radiol) (2008) 1.42
Neoadjuvant carboplatin before radiotherapy in stage IIA and IIB seminoma. Ann Oncol (2013) 1.41
Imaging with pentavalent [99mTc]DMSA in patients with medullary cancer of the thyroid. J Nucl Med (1988) 1.41
A meta-analysis of randomised trials suggests a survival benefit for combined radiotherapy and radical cystectomy compared with radical radiotherapy for invasive bladder cancer: are these data relevant to modern practice? Clin Oncol (R Coll Radiol) (2004) 1.41
A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy. Radiother Oncol (2001) 1.40
Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys (1999) 1.39
The effect of antiemetics and reduced radiation fields on acute gastrointestinal morbidity of adjuvant radiotherapy in stage I seminoma of the testis: a randomized pilot study. Clin Oncol (R Coll Radiol) (1997) 1.39
Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer (1981) 1.39
The clinical implications of the prostate cancer prevention trial. BJU Int (2003) 1.38
Bilateral testicular cancer: a preventable problem? Experience from a large cancer centre. BJU Int (2003) 1.38
Chloride and sodium influx: a coupled uptake mechanism in the squid giant axon. J Gen Physiol (1979) 1.36
Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning. Radiother Oncol (1997) 1.35
Effects of nystatin on membrane conductance and internal ion activities in Aplysia neurons. J Membr Biol (1977) 1.35
Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. Int J Radiat Oncol Biol Phys (2000) 1.34
Active transport of potassium by the giant neuron of the aplysia abdominal ganglion. J Gen Physiol (1972) 1.33
Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magn Reson Imaging (2000) 1.31
Effects of low temperature on the respiratory metabolism of carbohydrates by plants. Symp Soc Exp Biol (1988) 1.30
Antioxidant activity, packed cell transfusions, and outcome in premature infants. Arch Dis Child Fetal Neonatal Ed (1998) 1.28
Epithelial Membrane Antigen. Its use in the cytodiagnosis of malignancy in serous effusions. Am J Clin Pathol (1982) 1.28
Effect of nerve stimulation on the noradrenaline content of the spleen. Proc R Soc Lond B Biol Sci (1966) 1.27
Influences of array size and homogeneity on minisatellite mutation. EMBO J (1998) 1.26
Dynamic contrast-enhanced MRI for prostate cancer localization. Br J Radiol (2009) 1.26
GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol (1998) 1.24
Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol (1997) 1.24
Cation-coupled chloride influx in squid axon. Role of potassium and stoichiometry of the transport process. J Gen Physiol (1983) 1.23
NAD(P)H oxidase-derived superoxide mediates hypercholesterolemia-induced leukocyte-endothelial cell adhesion. Circ Res (2001) 1.22
Evaluating a designated family planning clinic within a genitourinary medicine clinic. Genitourin Med (1995) 1.22
Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res (2001) 1.22
Crossover breakpoint mapping identifies a subtelomeric hotspot for male meiotic recombination. Hum Mol Genet (2000) 1.22
Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. Scottish Gynaecological Cancer Trials Group. J Clin Oncol (1999) 1.22
Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. Br J Radiol (1991) 1.21
Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly. Radiother Oncol (1997) 1.21
Intracellular pH and Na fluxes in barnacle muscle with evidence for reversal of the ionic mechanism of intracellular pH regulation. J Gen Physiol (1983) 1.21
Bacteriological survey of acute appendicitis in children. Br J Surg (1976) 1.20
Quality control of bacterial enumeration. Appl Environ Microbiol (1993) 1.19
Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial. Br J Urol (1992) 1.18
Detection of isolated mammary carcinoma cells in marrow of patients with primary breast cancer. J R Soc Med (1983) 1.17